Spironolactone in atrial fibrillation with preserved cardiac contractility

2 September 2019 (08:30 - 08:48)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Eduard Shantsila

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail

Effects of Sacubitril-Valsartan Compared with Enalapril on Arterial Hemodynamics and Cardiac Remodeling in Patients with Heart Failure and Reduced Ejection Fraction

Doctor A. Desai (Boston, US)

Presentation thumbnail

Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on NT-proBNP and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: Primary Results of the PROVE-HF Study

Professor J. Januzzi (Boston, US)

Presentation thumbnail

Clinical effectiveness of primary prevention implantable defibrillators: results of the EU-CERT-ICD non-randomised, controlled, multicentre study

Associate Professor M. Zabel (Goettingen, DE)

Presentation thumbnail

Clinical phenotypes, gender differences and adverse events associated with truncating variants in the Titin (TTN) gene

Doctor M. Akhtar (London, GB)

Access the full session

Session thumbnail

Late Breaking Science in Heart Failure 1

The Event

ESC Congress 2019

2 September 2019 08:30 CET

You may be interested in

Congress Session

Improving patient outcomes in heart failure: the role of finerenone

19 May 2025

Congress Presentation

Rhythm control in clinical practice: case presentation

1 September 2024

Congress Presentation

1 September 2019

Congress Presentation

State-of-the-art lecture on novel mechanistic insights into arrhythmias

25 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources